5. Conclusions
OME
MIDDLE EAR, REMISSION
A 3-day course of mucolytics and steroid administration with AMSA was reported to be relatively effective for symptom withdrawal in adults with OME. Partial and complete OME remission was noted in, respectively, 81% and 39% of patients. Moreover, an increase in volume and pressure in the middle ear were observed following the treatment. Treatment efficacy did not depend on patients’ age, sex, or the season of inclusion in the trial. The results of this pilot study are encouraging; however, the use of AMSA management of OME in adults needs to be verified in future studies.